Going Nuclear 2: The Role of XPO1 in Diffuse Large B-cell Lymphoma

Join lymphoma experts Dr. Peter Martin, Dr. Erlene Seymour, and Dr. Tom Witzig for a discussion of recent advances in patient care. You will learn how inhibiting a key protein, XPO1, is impacting the current treatment paradigm.

Friday, January 22, 2021
1-2 PM (EST)

Peter Martin, MD
Weil Cornell Medicine
Erlene Seymour, MD
Karmanos Cancer Institute
Thomas E. Witzig, MD
Mayo Clinic